Clinical trial for Shoulder Osteoarthritis
Official title PRP for Glenohumeral Osteoarthritis
ClinicalTrials.gov ID: NCT05675527
What this study is testing
What is Low-dose PRP?
An investigational injectable treatment being studied for shoulder osteoarthritis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether different amounts of PRP help people with shoulder osteoarthritis. It also compares PRP to a saline shot.
- Who it's for
- You may be able to join if you have shoulder osteoarthritis and are not taking other experimental treatments.
- What's involved
- You will receive one injection of either low‑dose PRP, high‑dose PRP, or saline. After the injection, you will have follow‑up visits to check your shoulder.
- Time commitment
- The study lasts about 6 months, with a few visits after the injection to monitor your progress.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- 18-100 years old
- Average NRS pain greater than or equal to 5/10 as a direct result of glenohumeral osteoarthritis (any severity: mild, moderate, or severe) and/or...
- At least 3 months of pain after onset of symptoms that has failed conservative treatments, including physical therapy
- MRI of the affected joint
- Transient relief of symptoms after a diagnostic intra-articular injection into the joint
You likely can't join if
- Inability to hold non-steroidal anti-inflammatory drugs for 2 weeks prior and 1 month after the injection
- Prior platelet-rich plasma injection
- Steroid injection within 3 months of the initial injection
- Hyaluronic acid within 6 months of the initial injection
- Involved in workers' compensation or active litigation involving the affected joint
- History of Plavix use
See the full eligibility criteria
- 18-100 years old
- Average NRS pain greater than or equal to 5/10 as a direct result of glenohumeral osteoarthritis (any severity: mild, moderate, or severe) and/or chondral lesion or loss
- At least 3 months of pain after onset of symptoms that has failed conservative treatments, including physical therapy
- MRI of the affected joint
- Transient relief of symptoms after a diagnostic intra-articular injection into the joint
- Email address or network access
- Inability to hold non-steroidal anti-inflammatory drugs for 2 weeks prior and 1 month after the injection
- Prior platelet-rich plasma injection
- Steroid injection within 3 months of the initial injection
- Hyaluronic acid within 6 months of the initial injection
- Involved in workers' compensation or active litigation involving the affected joint
- History of Plavix use
- Known uncontrolled systemic illness (uncontrolled diabetes, HIV, vasculitis, autoimmune/autoinflammatory disease)
- Presence of acute fractures or gross mechanical deformities
- Concurrent "uncontrolled" cervical disorders
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Compensation & support
This study's listing mentions compensation or reimbursement.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.